Bentham Science Logo

Current Neuropharmacology

Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access

Ranking and Category

  • 59th of 267 in

    Neurosciences

  • 33rd of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Open Access Articles

Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

, 2019; 17(11): 1004 - 1020

Estefania Gastaldello Moreira*, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello and Michael Maes









Relevance of CYP2C9 Function in Valproate Therapy

, 2019; 17(1): 99 - 106

Katalin Monostory*, Andrea Nagy, Katalin Tóth, Tamás Bűdi , Ádám Kiss, Máté Déri and Gábor Csukly




Neuro-toxic and Reproductive Effects of BPA

, 2019; 17: 1 - 24 (E-Pub Ahead of Print)

Antonietta Santoro, Rosanna Chianese, Jacopo Troisi, Sean Richards, Stefania Lucia Nori, Silvia Fasano, Maurizio Guida, Elizabeth Plunck, Andrea Viggiano, Riccardo Pierantoni and Rosaria Meccariello*














cGMP Signaling, Phosphodiesterases and Major Depressive Disorder

, 2011; 9(4): 715 - 727

Gillian W. Reierson, Shuyu Guo, Claudio Mastronardi, Julio Licinio and Ma-Li Wong






Editor-in-Chief

T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK

Biography View Full Editorial Board

Journal History

Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Track Your Manuscript:


Scopus CiteScore Metrics: 3.02

New eBook

Neurobiology of Mood Disorders



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog